These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9253404)

  • 41. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
    Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N
    Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conformation and sandwiching of bases by azido groups in the crystal structure of 3'-azido-3'-deoxy-thymidine (AZT), an antiviral agent that inhibits HIV reverse transcriptase.
    Parthasarathy R; Kim H
    Biochem Biophys Res Commun; 1988 Apr; 152(1):351-8. PubMed ID: 2451915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of the 5'-phosphates of the anti-HIV agents, 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine, with thymidylate synthase.
    Dzik JM; Bretner M; Kulikowski T; Ciesla J; Ciesla JM; Rode W; Shugar D
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1418-23. PubMed ID: 3178819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis.
    Alnouti Y; White CA; Bartlett MG
    Biomed Chromatogr; 2004 Oct; 18(8):523-31. PubMed ID: 15386521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic transformation of AZTp4A by Ap4A hydrolase regenerates AZT triphosphate.
    Pitcher WH; Kirby TW; DeRose EF; London RE
    Antiviral Res; 2003 May; 58(3):227-33. PubMed ID: 12767470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a nucleotide binding site in HIV-1 integrase.
    Drake RR; Neamati N; Hong H; Pilon AA; Sunthankar P; Hume SD; Milne GW; Pommier Y
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4170-5. PubMed ID: 9539708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular thymidine kinase activity is required for the inhibition of HIV-1 replication by AZT in lymphocytes.
    Lowy I; Caruso M; Goff SP; Klatzmann D
    Virology; 1994 Apr; 200(1):271-5. PubMed ID: 8128627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An enzyme module system for the synthesis of dTDP-activated deoxysugars from dTMP and sucrose.
    Elling L; Rupprath C; Günther N; Römer U; Verseck S; Weingarten P; Dräger G; Kirschning A; Piepersberg W
    Chembiochem; 2005 Aug; 6(8):1423-30. PubMed ID: 15977277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.
    Gustafson EA; Schinazi RF; Fingeroth JD
    J Virol; 2000 Jan; 74(2):684-92. PubMed ID: 10623730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expressing engineered thymidylate kinase variants in human cells to improve AZT phosphorylation and human immunodeficiency virus inhibition.
    Wöhrl BM; Loubière L; Brundiers R; Goody RS; Klatzmann D; Konrad M
    J Gen Virol; 2005 Mar; 86(Pt 3):757-764. PubMed ID: 15722537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparative-scale high-performance liquid chromatographic separation and purification of 3'-azido-3'-deoxythymidine-5'-phosphate.
    Turcotte JG; Pivarnik PE; Shirali SS; Singh HK; Sehgal RK; Macbride D; Jang NI; Brown PR
    J Chromatogr; 1990 Jan; 499():55-61. PubMed ID: 2324213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of mammalian DNA polymerase-associated 3' to 5' exonuclease activity by 5'-monophosphates of 3'-azido-3'-deoxythymidine and 3'-amino-3'-deoxythymidine.
    Bridges EG; Faraj A; Sommadossi JP
    Biochem Pharmacol; 1993 Apr; 45(8):1571-6. PubMed ID: 8387298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of the reaction conditions for the synthesis of neoglycoprotein-AZT-monophosphate conjugates.
    Kuipers ME; Swart PJ; Hendriks MM; Meijer DK
    J Med Chem; 1995 Mar; 38(6):883-9. PubMed ID: 7699703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG; Anderson KS
    Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate.
    Ostermann N; Schlichting I; Brundiers R; Konrad M; Reinstein J; Veit T; Goody RS; Lavie A
    Structure; 2000 Jun; 8(6):629-42. PubMed ID: 10873853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decomposition of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate (AZTMP) prodrugs in biological media studied by on-line solid-phase extraction coupled to liquid chromatography mass spectrometry.
    Lefebvre I; Beltran T; Peyrottes S; Périgaud C
    Biomed Chromatogr; 2009 Nov; 23(11):1160-8. PubMed ID: 19444806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues.
    Matamoros T; Deval J; Guerreiro C; Mulard L; Canard B; Menéndez-Arias L
    J Mol Biol; 2005 Jun; 349(3):451-63. PubMed ID: 15878178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP.
    Balzarini J; Aquaro S; Knispel T; Rampazzo C; Bianchi V; Perno CF; De Clercq E; Meier C
    Mol Pharmacol; 2000 Nov; 58(5):928-35. PubMed ID: 11040039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.